epirubicin has been researched along with Urethral Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Canda, AE; Kirkali, Z; Mungan, MU; Tuzel, E; Yorukoglu, K | 1 |
| Aravantinos, G; Christodoulou, C; Dimopoulos, K; Fountzilas, G; Giannakakis, T; Kastriotis, I; Kostakopoulos, CA; Linardou, E; Picramenos, D; Skarlos, DV | 1 |
1 trial(s) available for epirubicin and Urethral Neoplasms
| Article | Year |
|---|---|
Chemotherapy with methotrexate, vinblastine, epirubicin and carboplatin (Carbo-MVE) in transitional cell urothelial cancer. A Hellenic Co-Operative Oncology Group study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystectomy; Disease Progression; Epirubicin; Female; Humans; Male; Methotrexate; Middle Aged; Treatment Outcome; Urethral Neoplasms; Urinary Bladder Neoplasms; Vinblastine; World Health Organization | 1997 |
1 other study(ies) available for epirubicin and Urethral Neoplasms
| Article | Year |
|---|---|
Conservative management of mucosal prostatic urethral involvement in patients with superficial transitional cell carcinoma of the bladder.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; BCG Vaccine; Carcinoma, Transitional Cell; Epirubicin; Follow-Up Studies; Humans; Male; Middle Aged; Mucous Membrane; Neoplasms, Multiple Primary; Prostatic Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms | 2004 |